Partnerships
Licensing
Collaborations
An IP Driven Business Model
Our core business model focuses on design, discovery, and engineering followed by protecting inventions as intellectual property and making strategic investments. We work closely with our partners to deliver innovative products to customers through mutually beneficial licensing and collaboration agreements.
Close Collaboration. Mutual Benefit.
Our partnering strategy is simple – identify outstanding teams who share our vision of creating exceptional molecular tools for nucleic acid detection. We are open to various arrangements such as exclusive or non-exclusive licensing with fees and/or royalties, R&D partnerships, in-licensing, and direct investment.
Vast Opportunities.
From Discovery to Market.
Our portfolio of engineered antibodies offer precise solutions for the sensing of modified DNA and RNA in a broad array of fundamental and applied life science markets.
Manufacturing and Quality Control
Therapeutics
Sequencing
Research
Immunoassay Kits
Diagnostics and Detection
Commitment to Science
Our core value is a deep commitment to the science of our inventions and strategic investments. We believe that creativity, rigor, and publication of science is central for genuine, multi-decade value creation for all.